Stanley C. Erck
2020
In 2020, Stanley C. Erck earned a total compensation of $48.1M as President and CEO at Novavax, a 1,872% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $591,463 |
|---|---|
| Option Awards | $44,115,244 |
| Salary | $657,181 |
| Stock Awards | $2,710,730 |
| Other | $11,400 |
| Total | $48,086,018 |
Erck received $44.1M in option awards, accounting for 92% of the total pay in 2020.
Erck also received $591.5K in non-equity incentive plan, $657.2K in salary, $2.7M in stock awards and $11.4K in other compensation.
Rankings
In 2020, Stanley C. Erck's compensation ranked 50th out of 13,090 executives tracked by ExecPay. In other words, Erck earned more than 99.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 50 out of 13,090 | 100th |
Division Manufacturing | 11 out of 5,624 | 100th |
Major group Chemicals And Allied Products | 4 out of 2,257 | 100th |
Industry group Drugs | 4 out of 1,957 | 100th |
Industry Biological Products, Except Diagnostic Substances | 2 out of 411 | 100th |
Pay ratio
| Stanley C. Erck's Pay | $48,086,018 |
|---|---|
| Median Employee's Pay | $400,755 |
| Pay Ratio | 120to 1 |
In 2020, the annual total compensation of Stanley C. Erck was $48,086,018.
The annual total compensation of the median employee at Novavax was $400,755.
The ratio of Stanley C. Erck's pay to the pay of median employee was therefore 120 to one.
Source: SEC filing on May 3, 2021.
Erck's colleagues
We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2020.